Omni Bio Pharmaceutical shutting down due to lack of funds

FORT COLLINS – Officials for Omni Bio Pharmaceutical Inc., a spinoff of University of Colorado technology, disclosed in a filing with the Securities and Exchange this week that the company will cease operations.

The filing stated that the Fort Collins-based company had been unsuccessful in raising funds and in its partnering and licensing efforts, making it unlikely that the firm could raise enough capital to continue operations.

“Consequently, the Board of Directors of the company has approved an orderly wind-down of the company, including negotiations with its senior secured creditor, Bohemian Investments, LLC,” the filing stated.

Officials for Omni Bio did not respond…